JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Testa, R.
Right arrow Articles by Leonardi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Testa, R.
Right arrow Articles by Leonardi, A.

Vol. 281, Issue 3, 1284-1293, 1997

Pharmacological Characterization of the Uroselective Alpha-1 Antagonist Rec 15/2739 (SB 216469): Role of the Alpha-1L Adrenoceptor in Tissue Selectivity, Part II

R. Testa, L. Guarneri, P. Angelico, E. Poggesi, C. Taddei, G. Sironi, D. Colombo, A. C. Sulpizio, D. P. Naselsky, J. P. Hieble and A. Leonardi

Pharmaceutical R&D Division, Recordati S.p.A., 20148 Milano, Italy (R.T., L.G., P.A., E.P., C.T., G.S., D.C., A.L.) and Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania (A.C.S., D.P.N., J.P.H.)

The aim of the present work was to investigate whether or not the uroselectivity of Rec 15/2739 and several other alpha-1 adrenoceptor (alpha 1-AR) antagonists observed in the anesthetized dog could be related to selectivity of these compounds for a particular alpha-1 AR subtype. The binding affinity of the tested compounds for canine prostate alpha-1 ARs and their in vitro functional affinity for the alpha-1 ARs of rabbit urethra and prostate correlated with their functional affinity for the alpha-1L AR subtype, but not with the binding affinity for recombinant animal and human alpha-1a, alpha-1b and alpha-1d AR subtypes. Similar results were obtained when the in vivo potency on urethral pressure was correlated with the affinity for the alpha-1 AR subtypes; also in this case alpha-1L AR gave the best correlation. No correlation was obtained by considering the other alpha-1 AR subtypes. The in vivo hypotensive effects observed in dog after i.v. administration of the considered compounds correlated only with the binding affinity for the animal and human alpha-1d subtype. In conclusion, the results shown in the present paper indicate that the potencies of different alpha-1 antagonists against the contractions induced by norepinephrine on tissues of the lower urinary tract of rabbits and dogs are better correlated with their affinity for the putative alpha-1L subtype than for the alpha-1a subtype. Only the compounds showing selectivity for the alpha-1L subtype versus the alpha-1d subtype proved highly selective in vivo for the lower urinary tract versus the vascular tissues.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Marti, R. Miquel, K. Ziani, R. Gisbert, M. D. Ivorra, E. Anselmi, L. Moreno, V. Villagrasa, D. Barettino, and P. D'Ocon
Correlation between mRNA levels and functional role of {alpha}1-adrenoceptor subtypes in arteries: evidence of {alpha}1L as a functional isoform of the {alpha}1A-adrenoceptor
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1923 - H1932.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Hiraizumi-Hiraoka, T. Tanaka, H. Yamamoto, F. Suzuki, and I. Muramatsu
Identification of {alpha}-1L Adrenoceptor in Rabbit Ear Artery
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 995 - 1002.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Hancock, S. A. Buckner, M. E. Brune, T. A. Esbenshade, L. M. Ireland, S. Katwala, I. Milicic, M. D. Meyer, J. F. Kerwin Jr., and M. Williams
Preclinical Pharmacology of Fiduxosin, a Novel alpha 1-Adrenoceptor Antagonist with Uroselective Properties
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 478 - 486.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Sironi, D. Colombo, E. Poggesi, A. Leonardi, R. Testa, O. Rampin, J. Bernabé, and F. Giuliano
Effects of Intracavernous Administration of Selective Antagonists of alpha 1-Adrenoceptor Subtypes on Erection in Anesthetized Rats and Dogs
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 974 - 981.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
E. E. Daniel, R. D. Brown, Y. F. Wang, A. M. Low, H. Lu-Chao, and C.-Y. Kwan
alpha -Adrenoceptors in Canine Mesenteric Artery Are Predominantly 1A Subtype: Pharmacological and Immunochemical Evidence
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 671 - 679.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
O. Rossier, L. Abuin, F. Fanelli, A. Leonardi, and S. Cotecchia
Inverse Agonism and Neutral Antagonism at alpha 1a- and alpha 1b-Adrenergic Receptor Subtypes
Mol. Pharmacol., November 1, 1999; 56(5): 858 - 866.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Akiyama, M. Hora, S. Tatemichi, N. Masuda, S. Nakamura, R. Yamagishi, and M. Kitazawa
KMD-3213, a Uroselective and Long-Acting alpha 1a-Adrenoceptor Antagonist, Tested in a Novel Rat Model
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 81 - 91.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Fukuta, Y. Fukuda, R. Higashino, K. Yoshida, M. Ogishima, H. Tamaki, and M. Takei
Z-350, A Novel Compound with alpha 1-Adrenoceptor Antagonistic and Steroid 5alpha -Reductase Inhibitory Actions: Pharmacological Properties In Vivo
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1013 - 1018.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. Low, H. Lu-Chao, Y. F. Wang, R. D. Brown, C. Y. Kwan, and E. E. Daniel
Pharmacological and Immunocytochemical Characterization of Subtypes of Alpha-1 Adrenoceptors in Dog Aorta
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 894 - 901.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.